View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Reed’s Schedules First Quarter 2024 Conference Call for May 14 at 5:00...

Reed’s Schedules First Quarter 2024 Conference Call for May 14 at 5:00 p.m. ET NORWALK, Conn., April 30, 2024 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Tuesday, May 14, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the three months ended March 31, 2024. The Company’s results will be reported in a press release prior to the call. Reed’s management will host the conference call, followed by a question-and-answer period. Da...

 PRESS RELEASE

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Compar...

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome Statistically Significant Improvements with DCCR Compared to Natural History of PWS from the PATH for PWS Study in Hyperphagia and PWS-related Behaviors REDWOOD CITY, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the publication of the comparison of results from the Company’s Phase ...

 PRESS RELEASE

HALLADOR ENERGY COMPANY TO ANNOUNCE FIRST QUARTER 2024 RESULTS

HALLADOR ENERGY COMPANY TO ANNOUNCE FIRST QUARTER 2024 RESULTS TERRE HAUTE, Ind., April 30, 2024 (GLOBE NEWSWIRE) -- Hallador Energy announced today that the company's first quarter 2024 financial results will be released after the market closes on Monday, May 6, 2024. Hallador Energy will host a conference call to discuss its results on Tuesday, May 7, 2024, at 2:00 p.m. EST. The call will be webcast live on the company’s website at under events and will be available for a limited time. Earnings Conference Call and Webcast DetailsPARTICIPANT INFORMATION:Operator Assisted Dial-...

 PRESS RELEASE

Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2023 Fi...

Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results 14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022$0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ($0.2 million) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs. fiscal 2022($1.4 million) net loss during the fourth quarter of fiscal 2023, compared to ($2.2 million) during the fourth quarter of fiscal 2022$15.0 million of Booked SaaS ACV as of January 31, 2024; $15.6 million of Booked SaaS ACV a...

 PRESS RELEASE

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S...

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS) First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned Submission of a New Drug Application (NDA) for DCCR Remains on Track for Mid-2024 REDWOOD CITY, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...

 PRESS RELEASE

Streamline Health® Expands eValuator™ Footprint With Existing Client

Streamline Health® Expands eValuator™ Footprint With Existing Client Following an efficient implementation process, a leading Florida-based healthcare provider is expanding its footprint and utilization of eValuator Atlanta, GA, April 29, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its existing contract with a 1,250 bed, Epic-based academic medical center serving central Florida. The health system recently completed its initial implementation of eValuator and ha...

 PRESS RELEASE

Streamline Health® Signs Second Enterprise Client

Streamline Health® Signs Second Enterprise Client 700-Bed health system adds eValuator™, becomes second healthcare provider leveraging both eValuator and RevID to improve revenue integrity pre-bill Atlanta, GA, April 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its partnership with a 5 facility, 700-bed Oracle EHR based health system. The system has been using RevID’s automated charge reconciliation for more than 2 years and has elected to add eValuator’s c...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 22, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Streamline Health® To Report Fourth Quarter and Fiscal Year 2023 Finan...

Streamline Health® To Report Fourth Quarter and Fiscal Year 2023 Financial Performance Atlanta, GA, April 22, 2024 (GLOBE NEWSWIRE) --  (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three and twelve month periods ended January 31, 2024 on Monday April 29, 2024 after the close of the financial markets. The Company will conduct a conference call on Tuesday, April 30, 2024, at 9:00 AM E...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 20, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 19, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing R...

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to six new employees. The independent members of the Board of Directors of Soleno approved the grant of non-qualified stock options to purchase 96,500 shares of common stock to six employees as an ind...

 PRESS RELEASE

Altair Announces Date of First Quarter 2024 Financial Results Conferen...

Altair Announces Date of First Quarter 2024 Financial Results Conference Call TROY, Mich., April 18, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ALTR), a global leader in computational intelligence, will release its financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024. On that day, management will hold a conference call and webcast at 5 p.m. ET to review and discuss the Company’s first quarter 2024 results and second quarter and full year 2024 outlook. A recorded version of this webcast will be available after the call and accessible at . Wh...

Workday Inc: 1 director

A director at Workday Inc sold 56,000 shares at 264.888USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Co...

Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th DENVER, April 16, 2024 (GLOBE NEWSWIRE) -- After the close of market trading on Tuesday, May 7, 2024, Angi Inc. (NASDAQ: ANGI) will post its first quarter results at . On Wednesday May 8, 2024, at 8:30 a.m. ET, Angi Inc. and IAC will host a conference call to answer questions regarding the companies’ respective first quarter results. The live audiocast and replay will be open to the public through the investor relations section of the Angi site at . About Angi Inc. Angi (NASDAQ: ANGI) helps...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 13, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 12, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 9, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Angi Appoints Jeff Kip as CEO

Angi Appoints Jeff Kip as CEO DENVER, April 08, 2024 (GLOBE NEWSWIRE) -- Angi (NASDAQ: ANGI), the leading and most comprehensive solution for all home care needs, today announced the appointment of Angi President and long-time IAC and Angi executive Jeff Kip to CEO, succeeding Joey Levin. As CEO, Mr. Kip will lead Angi’s executive team, overseeing strategy and daily management of the company. Mr. Levin, CEO of IAC, will continue as Chairman of the Angi Board of Directors. All changes are effective immediately. “Through multiple roles, Jeff Kip has been a student of the Angi business, fir...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 6, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch